Clearance has never been closer.

We're bringing a to and need .
In the US that is a 510(k) against a predicate, or De Novo when no predicate fits. We read every decision in your product code first.
7 sources lit for this brief
Start with this brief

New records land the day they post.

Clearances, approvals, recalls and new trials arrive as the agencies publish them, and each one reaches every company whose map it touches. These are real records from the last few weeks.
973 device decisions since 1 August
512 recalled products since 1 July
395 device trials now recruiting
  • K253422 · 510(k) cleared
    2 Oct
    Cognition Medical Corp. · Cardiovascular · Class II · QJP
  • P150012 · PMA decision
    3 Oct
    Boston Scientific · Cardiovascular · Class III · LWP
  • NCT07885176 · Recruiting
    Aug
    Device study in tinnitus · 60 participants
  • K254030 · 510(k) cleared
    2 Oct
    VPIX Medical, Inc. · Neurology · Class II · QFX
  • Steris Corporation · Recall
    Jul to Oct
    Software may mismatch patient details on printed images
  • K260064 · 510(k) cleared
    2 Oct
    Argus Cognitive, Inc. · Neurology · Class II · QPF

Find your predicate. Trace the whole chain.

Name your device and we walk its product code back through every cleared predicate to the device that was on the market before the 1976 amendments.

Choose the pathway. See the calendar it sets.

510(k), De Novo or PMA. Each sets an FDA review goal, the evidence you need and what you can claim on the label.

Check your freedom to operate.

We place your claims among the patents filed in your classes, and flag the ones that sit close enough to read in full before you build.

Plan the trial. Learn from the ones recruiting.

See what similar device studies enroll, where their sites are and what they measure, before you write your protocol.

Get paid for it. Code, coverage, rate.

A cleared device still needs a code, a coverage decision and a payment rate. We trace each one from the codes your peers already bill.

Launch where the procedures happen.

Rank hospitals and physicians by how often they do the procedure, see who already works with your competitors, and staff the first accounts.
Predicate chain
Your device
Class II · the product code you name
Its predicate
Cleared through a 510(k) in the same code
The predicate’s predicate
Substantially equivalent, one step back
A device sold before 28 May 1976
Where the chain of equivalence starts
Review goals in FDA days
510(k)
90 days
De Novo
150 days
PMA
180 days
Since 1 August our records hold 599 510(k) decisions. A 510(k) needs a predicate in your product code, and most need no clinical study.
Patent field
Example
Your claims
Read in full
Nearby
Same classes
Device trials recruiting now
Tinnitus
NCT07885176
60 participants planned
Obesity, BMI over 35
NCT07884994
50 participants planned
Rotator cuff disease
NCT07886827
40 participants planned
Anxiety and pain in children under anesthesia
NCT07886333
40 participants planned
From procedure to payment
Procedure
What the physician does with your device
Code
A CPT or HCPCS code that describes it
Coverage
A national or local coverage decision
Rate
The fee schedule amount per setting
New technology add-on. If your device is new and costly, an inpatient add-on payment can bridge the gap.
First accounts
Example
1
Academic medical centre, Midwest
1,240
2
Regional heart institute, Southeast
1,105
3
Integrated health system, West
930
4
Community hospital network, Northeast
760
5
Ambulatory surgery centre group, Texas
610
6
Teaching hospital, Mid-Atlantic
540
Procedures a year in the example. Your list comes from Medicare provider volume and Open Payments.
Get started

Five studies in a row. Or all five at once.

A consultant runs regulatory strategy, predicates, payment, trials and market sizing one after another, each from its own spreadsheet. Here they run together, against the same records, and each one updates the others.
Regulatory strategy
Predicate search
Reimbursement
Trial landscape
Market sizing
Commercializer
Start
Finish

Every milestone, on one calendar.

Your intake becomes a plan: each product’s pathway and its review clock, the payment work, the raise and the launch, with what has to finish before what. Scroll to move the calendar.
0 of 17 done by Jan 2027
Lumen Vascular · launch plan
Example
Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028Q3 2028Q4 2028Q1 2029FundingSizing catheter · 510(k)Drug-coated balloon · PMAPaymentCommercialSeries B raiseDesign verification510(k) submittedFDA review · 90 daysClearedUS launchIDE study enrollment12-month follow-upPMA submittedFDA review · 180 daysApprovedCategory III CPT codeCoverage dossierAdd-on payment requestOpinion-leader programSales team hiringFirst accountsToday

Your company, drawn as you answer.

Every answer in the intake becomes a node, and the records behind it hang from it.
  • Profile
    Stage, funding, size and markets
  • Areas
    The therapeutic areas and MeSH headings
  • Products
    Each with its class and pathway
  • Sources
    The datasets read for each product
  • Team
    People, and the agents beside them
LUMENVASCULARProfileSeries A11–50 peopleUnited StatesEuropean UnionDeviceAreasCardiovascularRadiologyPeripheral arterial diseaseAngioplastyAngiographyProductsDrug-coated balloonSizing catheterImaging softwareClass IIIPMAClass II510(k)510(k)Sources510(k) clearancesPMA approvalsMAUDE eventsDevice recallsClinicalTrials.govMedicare volumePatentsTeamChief executiveRegulatory leadMarket access leadClinical leadRegulatory agentReimbursement agentTrials agent

Your people, with agents beside them.

Put your regulatory, clinical and market access leads on the map, and give each an agent that reads the records for them overnight.
MO
Maya Okafor
Chief executive
Reviews what the agents draft each morning
Regulatory agent
Works for the regulatory lead
DR
Daniel Reyes
Regulatory lead
Reviews what the agents draft each morning
Reimbursement agent
Works for market access
PR
Priya Raman
Clinical lead
Reviews what the agents draft each morning
Trials agent
Works for the clinical lead
315

Datasets, read for your company first.

Your intake picks which tables get read for you, from FDA decisions to fee schedules to patents, and every finding cites the record it came from.
510(k) clearances
PMA approvals
De Novo decisions
MAUDE adverse events
GUDID identifiers
Device recalls
EUDAMED devices
EUDAMED certificates
Health Canada licences
Australian device register
510(k) clearances
PMA approvals
De Novo decisions
MAUDE adverse events
GUDID identifiers
Device recalls
EUDAMED devices
EUDAMED certificates
Health Canada licences
Australian device register
China device codes
Japan DPC fees
ClinicalTrials.gov
PubMed
FDA guidance
Drug labels
FAERS reports
ChEMBL mechanisms
Patents
SEC filings
China device codes
Japan DPC fees
ClinicalTrials.gov
PubMed
FDA guidance
Drug labels
FAERS reports
ChEMBL mechanisms
Patents
SEC filings
XBRL financials
Insider trades
13F holdings
Open Payments
NPPES providers
Medicare provider volume
Product classifications
Crosswalks
XBRL financials
Insider trades
13F holdings
Open Payments
NPPES providers
Medicare provider volume
Product classifications
Crosswalks

Start with your company. The map draws itself.

Twenty questions, one per screen. Every answer becomes a node, and the right records come with it.
Get started